世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

バイオテクノロジー、医薬品開発、ドラッグデリバリーシステムにおけるナノ粒子


Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems

レポートの範囲 本レポートの対象範囲には、バイオテクノロジー、医薬品開発・製剤、ドラッグデリバリーシステム、診断におけるナノ粒子の世界市場の概要や、2022年を基準年として2023年から2028年までの市場... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
BCC Research
BCCリサーチ
2023年6月20日 US$5,500
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
174 英語

 

サマリー

レポートの範囲

本レポートの対象範囲には、バイオテクノロジー、医薬品開発・製剤、ドラッグデリバリーシステム、診断におけるナノ粒子の世界市場の概要や、2022年を基準年として2023年から2028年までの市場規模を年平均成長率(CAGR)予測とともに分析した世界市場動向の分析が含まれます。

本レポートには、ナノ粒子タイプごとの主要医薬品と新興医薬品の分析が含まれています。主要製品のメーカーとその具体的な製品のプロフィールを掲載しています。また本レポートでは、予測期間中に製品を投入する企業を評価し、これらの投入が競争環境の様相をどのように変えるかについて論じています。競争環境については、新製品がナノ粒子関連薬剤を投与される患者のQOLをどのように変化させるかに特に焦点を当てて検証しています。

市場の数値はメーカーレベルの収益に基づいており、ドル建てで予測しています。予測数値にはインフレは計算されていません。トレンドは、既存製品の売上予測、新製品の導入、既存製品の市場拡大、および市場に影響を与えるその他の要因に基づいて評価されます。

本調査では、既存のナノ粒子技術および医薬品市場の概要を提供するために、ナノ製品、企業、地域、作用機序ごとに整理し、予測を地域別および国別に分類してカバーしています。様々なナノ医薬品候補の特許と臨床試験情報をレビューしています。FDAや他国の規制当局による各分野の医薬品の承認状況をレビューしています。

数値は米ドルで報告されており、各事例は収益変動の実績の中で為替変動を反映している。売上高の数値は現地通貨の変動を考慮していない。すべての市場シェアは、特に記載がない限りグローバル・ベースである。

地域別分析には、北米(米国、カナダ、メキシコ)、欧州(英国、ドイツ、フランス、スペイン、イタリア、その他の欧州地域)、アジア太平洋地域(中国、インド、日本、その他のアジア太平洋地域)、その他の地域(南米、中東、アフリカ)が含まれる。

レポートは以下を含む:

- 25のデータ表と40の追加表
- バイオテクノロジー、医薬品開発、ドラッグデリバリーシステムにおけるナノ粒子の世界市場の最新概要と詳細分析
- 2020年から2022年までの過去の市場収益データ(売上高)、2023年の予測、2028年までの複合年間成長率(CAGR)の予測による世界市場動向の分析
- バイオテクノロジー、医薬品開発、ドラッグデリバリーシステムにおけるナノ粒子市場の実際の市場規模および収益予測、対応する技術別、用途別、地域別の市場シェア分析
- 医薬品開発、製剤化、新薬物送達システム開発のハイライトと、健康とウェルネスのサブセグメント内の詳細な製品分析
- 特定の成長トレンド、今後の技術、展望、市場全体への貢献に関して、市場の進展に影響を与える主要要因(利益と業界特有の課題)に関する詳細情報(事実と数値
- COVID-19ワクチン製造におけるナノテクノロジーの役割、作用機序、COVID-19のワクチン設計におけるコンポーネントと方法、ワクチン破壊の課題に関する考察
- 各ナノ粒子タイプの主要な医薬品および新興医薬品のレビュー、様々なナノ医薬品候補の臨床試験状況、各セグメントにおける医薬品の承認状況、エコシステム内での技術および研究イニシアチブの浸透状況
- バイオテクノロジー、医薬品開発、ドラッグデリバリーシステムにおけるナノ粒子に関する特許と特許出願の最新情報、および関連科学出版物
- 主要な利害関係者の特定と、最近の動向、財務実績、セグメント別の収益に基づく競争状況の分析
- ブリストル・マイヤーズ スクイブ社、カムラス社、グラクソ・スミスクラインPLC、Merck & Co.Inc.、ノバルティスAGなど

ページTOPに戻る


目次

Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
What's New in This Report?
Scope of Report
Methodology
Market Estimate
Information Sources
Primary Research
Secondary Research
Geographic Breakdown
Market Segmentation
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market Overview
Introduction to Nanoparticles
Liposomes
Quantum Dots
Dendrimers
Macromolecule Nanoparticles
Brief History of Nanoparticles
Nanoparticles in Biotechnology
Nanoparticles in Drug Development
Nanoparticles in Drug Delivery Systems
Nanoparticles in Diagnostic Imaging
Major Players in the Nanoparticle Drug Delivery Field
Major Nanoparticle/Nanocrystal Drugs
Market Dynamics
Drivers
Restraints
PESTEL Analysis
Regulatory Landscape
U.S.
Europe
India
Emerging Technologies in Nanoparticles
Gadolinium-Neutron Capture Therapy (Gd-NCT) for Glioblastoma Multiforme (GBM) Treatment
Ligand-tethered Lipid Nanoparticles for Targeted RNA Delivery to treat Liver Fibrosis
Chapter 4 Role of Nanotechnology in COVID-19 Vaccine Production
Introduction
Fight Against Novel Coronavirus
Structure of COVID-19 and Penetration
Challenges for COVID-19 Vaccines
Components and Methods in the Design of Vaccines
Antigen
Adjuvant
Nanoparticle/Nanocarrier
Device
Next-Generation Vaccines Enabled Through Advances in Nanotechnology
Conclusion on Nanotechnology Use Against COVID-19
Chapter 5 Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems by Technology
Technology Overview
Liposomes
Polymeric Micelles
Dendrimers
Others
Chapter 6 Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems by Application
Biotechnology
Drug Development and Formulation
Drug Delivery Systems
Diagnostic Imaging
Chapter 7 Structure of Nanoparticles
Adoption of Nanoparticles in Applied Markets
Liquid Crystals
Liquid Carriers
Liposomes
Dendrimers
Chitosan and Alginate
Nanocrystals
Quantum Dots
Application of Nanoparticles to Drugs Delivered
Chapter 8 Production of Nanoparticles
Methods of Nanoparticle Formation
Self-Assembly Production
Methods of Stabilization
Methods of Drug Introduction
Polymeric Nanoparticles
Micelles
Liposomes
Gold and Silicon Nanoparticles
Dendrimers
Methods for Loading Biological Molecules into Nanoparticles
Nanocrystal Drugs
Problems with Large-Scale Nanoparticle Production
Chapter 9 Nanoparticles in Biotechnology
Research and Development
Stem Cell Research
Cellular Repair
Paramagnetic and Superparamagnetic Nanoparticles
Biosensors and Quantum Dots
Nanoparticle Research Collaborative Programs
Chapter 10 Nanoparticles in Drug Development and Formulation
Bio Separations
Rapid Drug Analysis
Removal of Impurities and Toxins
Using Nanoparticles to Incorporate Insoluble Drugs
Gold and Silver Nanoparticles in Biomedicine
DNA Nanoparticle Development of DNA-Specific Drugs
Chapter 11 Nanoparticles in Drug Delivery Systems
Nanoparticles in Drug Delivery Applications
Designing a Nanoparticle Drug Delivery System
Nanoparticle Drug Stability
Size Homogeneity of Nanoparticle Preparations
Drug Loading of Nanoparticles
Drug Release from Nanoparticles
External Triggers for Releasing Drugs from Nanoparticles
Binding/Incorporation of Biomolecules to Nanoparticles
Nanoparticle Toxicity
Large-Scale Manufacturing
Methods of Administration of Nanoparticle Drugs
Oral Administration
Injection Administration
Transdermal Patch
Implantation Administration
Inhalation Administration
Nanoparticles Suitable for Drug Delivery Systems
Lipid-Based Nanoparticles
Micelle Nanoparticles
Dendrimer Nanoparticles
Polymeric Nanoparticles
Metal-Based Nanoparticles
Biological Macromolecule Nanoparticles
Nanocrystals
Nanoparticle Drug Delivery Systems Now Available
Antibiotic Nanoparticles
Anti-Tumor and Small Molecule Delivery by Nanoparticle
Release of Anti-Cancer Drugs from Nanoparticles
Biomacromolecules Delivered by Nanoparticles
Nanoparticles Coating for Drug Delivery Systems
Removal of Nanoparticles from the Body
Chapter 12 In Vitro and In Vivo Diagnostic Imaging
In Vitro Imaging
Nanoparticles in Diagnostic Imaging
Chapter 13 Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems by Region
Market Overview and Discussion
North America
Europe
Asia-Pacific
Rest of the World
South America
Middle East and Africa
Chapter 14 Competitive Landscape
Nanoparticle Drug Delivery Systems and Products
Major Players in Nanoparticle Drug Delivery Systems
Company Pipelines for Nanoparticle Drug Delivery
Drivers of Nanoparticle Products and Marketing
Limiters of Nanoparticle Product Development and Marketing
Chapter 15 Patents, Licensing, Mergers and Acquisitions
Recent Licensing Activity, Mergers, and Acquisition
Recent Deals
Nanoparticle Patents
Chapter 16 Company Profiles
BRISTOL-MYERS SQUIBB CO.
CAMURUS AB
CERAMISPHERE HEALTH PTY LTD.
CYTIMMUNE SCIENCES
GILEAD SCIENCES INC.
GLAXOSMITHKLINE PLC
HOFFMANN-LA ROCHE INC.
MERCK & CO. INC.
NANOCARRIER CO., LTD.
NOVARTIS AG

 

ページTOPに戻る


 

Summary

Report Scope:

The scope of the report includes an overview of the global market for nanoparticles in biotechnology, drug development and formulation, drug delivery systems, and diagnostics as well as analyses of global market trends, using 2022 as the base year and forecasting market sizes for 2023 through 2028 with compound annual growth rate (CAGR) projections.

The report includes an analysis of leading and emerging drug products for each nanoparticle type. Profiles of manufacturers of leading products and their specific products are provided. This report also assesses companies poised to introduce products during the forecast period and discusses how these introductions will change the face of the competitive environment. The competitive environment is examined with a special focus on how new products will alter the quality of life of patients receiving nanoparticle-associated drugs.

Market figures are based on revenues at the manufacturer level and are projected in dollar value. Inflation is not computed into the projection figures. Trends are assessed based on projected sales for existing products, new product introductions, expanded markets for existing products, and other factors affecting the market.

The study is arranged to offer an overview of existing nanoparticle technology and drug markets; it is accompanied by nanoproduct, company, geography, and mechanism of action, with forecasts broken down and covered by geographic regions and countries. Patent and clinical trial information is reviewed for various candidate nanodrugs. The status of approvals of drugs in each segment by the FDA and regulatory agencies in other countries is reviewed.

Figures are reported in U.S. dollars and each case reflects currency fluctuations within the performance of revenue change. Revenue figures do not account for variations in local currencies. All market share data presented is on a global basis unless specifically mentioned.

Regional analysis includes North America (U.S., Canada, Mexico), Europe (U.K., Germany, France, Spain, Italy, and the Rest of Europe), Asia-Pacific (China, India, Japan, and Rest of Asia-Pacific), and the Rest of the world (South America, and the Middle East and Africa).

Report Includes:

- 25 data tables and 40 additional tables
- An updated overview and in-depth analysis of the global markets for nanoparticles in biotechnology, drug development and drug delivery systems
- Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
- Estimation of the actual market size and revenue forecast for nanoparticles in biotechnology, drug development and drug delivery systems market, and corresponding market share analysis by technology, application and region
- Highlights of the drug development, formulation, and the development of new drug delivery systems and detailed product analyses within health and wellness subsegments
- In-depth information (facts and figures) concerning the major factors influencing the progress of the market (benefits and industry-specific challenges) with respect to specific growth trends, upcoming technologies, prospects, and contributions to the overall market
- Discussion on the role of nanotechnology in the COVID-19 vaccine production, mechanism of action, components and methods in vaccine design for COVID-19 and challenges for vaccine disruptions
- Review of the leading and emerging drug products for each nanoparticle type, clinical trial landscape for various candidate nanodrugs, status of approvals of drugs in each segment, and penetration of technologies and research initiatives within the ecosystem
- Updated information on patents and patent applications on nanoparticles in biotechnology, drug development and drug delivery systems, and related scientific publications
- Identification of the major stakeholders and analysis of the competitive landscape based on recent developments, financial performances, and segmental revenues
- Descriptive company profiles of the leading global players in the market, including Bristol-Myers Squibb Co., Camurus, GlaxoSmithKline PLC, Merck & Co. Inc. and Novartis AG



ページTOPに戻る


Table of Contents

Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
What's New in This Report?
Scope of Report
Methodology
Market Estimate
Information Sources
Primary Research
Secondary Research
Geographic Breakdown
Market Segmentation
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market Overview
Introduction to Nanoparticles
Liposomes
Quantum Dots
Dendrimers
Macromolecule Nanoparticles
Brief History of Nanoparticles
Nanoparticles in Biotechnology
Nanoparticles in Drug Development
Nanoparticles in Drug Delivery Systems
Nanoparticles in Diagnostic Imaging
Major Players in the Nanoparticle Drug Delivery Field
Major Nanoparticle/Nanocrystal Drugs
Market Dynamics
Drivers
Restraints
PESTEL Analysis
Regulatory Landscape
U.S.
Europe
India
Emerging Technologies in Nanoparticles
Gadolinium-Neutron Capture Therapy (Gd-NCT) for Glioblastoma Multiforme (GBM) Treatment
Ligand-tethered Lipid Nanoparticles for Targeted RNA Delivery to treat Liver Fibrosis
Chapter 4 Role of Nanotechnology in COVID-19 Vaccine Production
Introduction
Fight Against Novel Coronavirus
Structure of COVID-19 and Penetration
Challenges for COVID-19 Vaccines
Components and Methods in the Design of Vaccines
Antigen
Adjuvant
Nanoparticle/Nanocarrier
Device
Next-Generation Vaccines Enabled Through Advances in Nanotechnology
Conclusion on Nanotechnology Use Against COVID-19
Chapter 5 Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems by Technology
Technology Overview
Liposomes
Polymeric Micelles
Dendrimers
Others
Chapter 6 Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems by Application
Biotechnology
Drug Development and Formulation
Drug Delivery Systems
Diagnostic Imaging
Chapter 7 Structure of Nanoparticles
Adoption of Nanoparticles in Applied Markets
Liquid Crystals
Liquid Carriers
Liposomes
Dendrimers
Chitosan and Alginate
Nanocrystals
Quantum Dots
Application of Nanoparticles to Drugs Delivered
Chapter 8 Production of Nanoparticles
Methods of Nanoparticle Formation
Self-Assembly Production
Methods of Stabilization
Methods of Drug Introduction
Polymeric Nanoparticles
Micelles
Liposomes
Gold and Silicon Nanoparticles
Dendrimers
Methods for Loading Biological Molecules into Nanoparticles
Nanocrystal Drugs
Problems with Large-Scale Nanoparticle Production
Chapter 9 Nanoparticles in Biotechnology
Research and Development
Stem Cell Research
Cellular Repair
Paramagnetic and Superparamagnetic Nanoparticles
Biosensors and Quantum Dots
Nanoparticle Research Collaborative Programs
Chapter 10 Nanoparticles in Drug Development and Formulation
Bio Separations
Rapid Drug Analysis
Removal of Impurities and Toxins
Using Nanoparticles to Incorporate Insoluble Drugs
Gold and Silver Nanoparticles in Biomedicine
DNA Nanoparticle Development of DNA-Specific Drugs
Chapter 11 Nanoparticles in Drug Delivery Systems
Nanoparticles in Drug Delivery Applications
Designing a Nanoparticle Drug Delivery System
Nanoparticle Drug Stability
Size Homogeneity of Nanoparticle Preparations
Drug Loading of Nanoparticles
Drug Release from Nanoparticles
External Triggers for Releasing Drugs from Nanoparticles
Binding/Incorporation of Biomolecules to Nanoparticles
Nanoparticle Toxicity
Large-Scale Manufacturing
Methods of Administration of Nanoparticle Drugs
Oral Administration
Injection Administration
Transdermal Patch
Implantation Administration
Inhalation Administration
Nanoparticles Suitable for Drug Delivery Systems
Lipid-Based Nanoparticles
Micelle Nanoparticles
Dendrimer Nanoparticles
Polymeric Nanoparticles
Metal-Based Nanoparticles
Biological Macromolecule Nanoparticles
Nanocrystals
Nanoparticle Drug Delivery Systems Now Available
Antibiotic Nanoparticles
Anti-Tumor and Small Molecule Delivery by Nanoparticle
Release of Anti-Cancer Drugs from Nanoparticles
Biomacromolecules Delivered by Nanoparticles
Nanoparticles Coating for Drug Delivery Systems
Removal of Nanoparticles from the Body
Chapter 12 In Vitro and In Vivo Diagnostic Imaging
In Vitro Imaging
Nanoparticles in Diagnostic Imaging
Chapter 13 Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems by Region
Market Overview and Discussion
North America
Europe
Asia-Pacific
Rest of the World
South America
Middle East and Africa
Chapter 14 Competitive Landscape
Nanoparticle Drug Delivery Systems and Products
Major Players in Nanoparticle Drug Delivery Systems
Company Pipelines for Nanoparticle Drug Delivery
Drivers of Nanoparticle Products and Marketing
Limiters of Nanoparticle Product Development and Marketing
Chapter 15 Patents, Licensing, Mergers and Acquisitions
Recent Licensing Activity, Mergers, and Acquisition
Recent Deals
Nanoparticle Patents
Chapter 16 Company Profiles
BRISTOL-MYERS SQUIBB CO.
CAMURUS AB
CERAMISPHERE HEALTH PTY LTD.
CYTIMMUNE SCIENCES
GILEAD SCIENCES INC.
GLAXOSMITHKLINE PLC
HOFFMANN-LA ROCHE INC.
MERCK & CO. INC.
NANOCARRIER CO., LTD.
NOVARTIS AG

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD(biotechnology)の最新刊レポート


よくあるご質問


BCC Research社はどのような調査会社ですか?


BCCリサーチ(BCC Research)は1971年に設立され、様々な業界経験を持つアナリストと編集者によりトップクラスの市場情報源を長年提供している調査会社です。   設立初期は先端材料とプラ... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/20 10:28

158.95 円

165.20 円

201.28 円

ページTOPに戻る